Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
July 11 2023 - 3:51PM
Edgar (US Regulatory)
As
filed with the U.S. Securities and Exchange Commission on July 11, 2023
Registration
Statement No. 333-273169
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
PRE-EFFECTIVE
AMENDMENT NO. 1
TO
FORM
S-3
REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933
Xtant
Medical holdings, Inc.
(Exact
name of registrant as specified in its charter)
Delaware |
|
20-5313323 |
(State
or other jurisdiction of
incorporation
or organization) |
|
(I.R.S.
Employer
Identification
Number) |
664
Cruiser Lane
Belgrade,
Montana 59714
(406)
388-0480
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Sean
E. Browne
President
and Chief Executive Officer
Xtant
Medical Holdings, Inc.
664
Cruiser Lane
Belgrade,
Montana 59714
(406)
388-0480
(Name,
address, including zip code, and telephone number, including area code, of agent for service)
Copies
to:
Amy
E. Culbert, Esq.
Emily
Humbert, Esq.
Fox
Rothschild LLP
City
Center
33
South Sixth Street, Suite 3600
Minneapolis,
Minnesota 55402
(612)
607-7000
Approximate
date of commencement of proposed sale to the public: From time to time after this registration statement becomes effective as determined
by the selling stockholders.
If
the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check
the following box: ☐
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following
box: ☒
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective
upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated
filer ☐ |
Accelerated filer
☐ |
|
Non-accelerated filer ☒ |
Smaller reporting company
☒ |
|
|
Emerging growth company ☐ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The
Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date
as the Commission, acting pursuant to said section 8(a), may determine.
EXPLANATORY
NOTE
This
Pre-Effective Amendment No. 1 (this “Amendment”) to the Registration Statement on Form S-3 (File No. 333-273169) (the “Registration
Statement”) of Xtant Medical Holdings, Inc. (the “Company”) is being filed solely to file an additional consent of
Plante & Moran, PLLC, the Company’s independent registered public accounting firm, as Exhibit 23.3 to the Registration Statement.
Accordingly, this Amendment consists solely of the facing page, this Explanatory Note, Item 16 of Part II of the Registration Statement,
the signature page, Exhibit 23.1 and Exhibit 23.3. The prospectus and the balance of Part II of the Registration Statement are unchanged
and have been omitted.
PART
II — INFORMATION NOT REQUIRED IN PROSPECTUS
Item
16. Exhibits and Financial Statement Schedules
|
Exhibit
No. |
|
Description |
|
|
|
|
|
3.1 |
|
Amended and Restated Certificate of Incorporation of Xtant Medical Holdings, Inc. (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 13, 2018 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
3.2 |
|
Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Xtant Medical Holdings, Inc. (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on October 31, 2019 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
3.3 |
|
Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Xtant Medical Holdings, Inc., as amended (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on October 1, 2020 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
3.4 |
|
Third Amended and Restated Bylaws of Xtant Medical Holdings, Inc. (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 19, 2023 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
4.1 |
|
Form of Common Stock Certificate (filed as Exhibit 4.2 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 8, 2022 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
4.2 |
|
Investor Rights Agreement dated February 14, 2018 by and among Xtant Medical Holdings, Inc., OrbiMed Royalty Opportunities II, LP, ROS Acquisition Offshore LP, Park West Partners International, Limited and Park West Investors Master Fund, Limited (filed as Exhibit 10.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 16, 2018 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
4.3 |
|
Registration Rights Agreement (for Common Stock underlying the Indenture Notes) dated January 17, 2017 by and among Xtant Medical Holdings, Inc., ROS Acquisition Offshore LP and OrbiMed Royalty Opportunities II, LP. (filed as Exhibit 10.9 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 20, 2017 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
4.4 |
|
Registration Rights Agreement (for Common Stock underlying the PIK Notes) dated January 17, 2017 by and among Xtant Medical Holdings, Inc., ROS Acquisition Offshore LP and OrbiMed Royalty Opportunities II, LP. (filed as Exhibit 10.13 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 20, 2017 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
4.5 |
|
Registration Rights Agreement (for Common Stock issued upon the exchange of the Notes and pursuant to the Private Placement) dated as of February 14, 2018 by and among Xtant Medical Holdings, Inc., OrbiMed Royalty Opportunities II, LP, ROS Acquisition Offshore LP, Telemetry Securities, L.L.C., Bruce Fund, Inc., Park West Investors Master Fund, Limited, and Park West Partners International, Limited (filed as Exhibit 10.4 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 16, 2018 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
4.6 |
|
Registration Rights Agreement dated October 1, 2020 by and among Xtant Medical Holdings, Inc., OrbiMed Royalty Opportunities II, LP, and ROS Acquisition Offshore LP (filed as Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on October 1, 2020 (SEC File No. 001-34951) and incorporated by reference herein) |
|
4.7 |
|
Registration Rights Agreement dated February 24, 2021 by and between Xtant Medical Holdings, Inc. and the investor party thereto (filed as Exhibit 4.4 to the Registrant’s Registration Statement on Form S-3 filed with the SEC on April 6, 2021 (Sec File No. 333-255074) and incorporated by reference herein) |
|
|
|
|
|
4.8 |
|
Registration Rights Agreement, dated as of August 25, 2022, by and among Xtant Medical Holdings, Inc. and the investors party thereto (filed as Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on August 31, 2022 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
4.9 |
|
Registration Rights Agreement, dated as of July 6, 2023, by and among Xtant Medical Holdings, Inc. and the investors party thereto (filed as Exhibit 4.9 to the Registrant’s Registration Statement on Form S-3 filed with the SEC on July 7, 2023 (SEC File No. 333-273169) and incorporated by reference herein) |
|
|
|
|
|
4.10 |
|
Form of Investor Warrant (filed as Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 22, 2021 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
4.11 |
|
Form of Placement Agent Warrant (filed as Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 22, 2021 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
4.12 |
|
Form of Warrant (filed as Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on August 24, 2022 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
5.1 |
|
Opinion of Fox Rothschild LLP (filed as Exhibit 5.1 to the Registrant’s Registration Statement on Form S-3 filed with the SEC on July 7, 2023 (SEC File No. 333-273169) and incorporated by reference herein) |
|
|
|
|
|
10.1 |
|
Securities Purchase Agreement, dated as of July 3, 2023, by and among Xtant Medical Holdings, Inc. and the investors party thereto (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on July 3, 2023 (SEC File No. 001-34951) and incorporated by reference herein) |
|
|
|
|
|
23.1* |
|
Consent of Independent Registered Public Accounting Firm, Plante & Moran, PLLC |
|
|
|
|
|
23.2 |
|
Consent of Fox Rothschild LLP (included in Exhibit 5.1 to the Registrant’s Registration Statement on Form S-3 filed with the SEC on July 7, 2023 (SEC File No. 333-273169) and incorporated by reference herein) |
|
|
|
|
|
23.3* |
|
Consent of Independent Registered Public Accounting Firm, Plante & Moran, PLLC |
|
|
|
|
|
24.1 |
|
Power of Attorney (included on signature page to the Registrant’s Registration Statement on Form S-3 filed with the SEC on July 7, 2023 (SEC File No. 333-273169) and incorporated by reference herein) |
|
|
|
|
|
107 |
|
Calculation of Filing Fee Tables (filed as Exhibit 107 to the Registrant’s Registration Statement on Form S-3 filed with the SEC on July 7, 2023 (SEC File No. 333-273169) and incorporated by reference herein) |
|
(b) |
Financial Statement Schedules |
Schedules
have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements
or notes thereto.
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-3 and has duly caused this Pre-Effective Amendment No. 1 to registration statement
to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Belgrade, State of Montana, on July 11, 2023.
|
XTANT
MEDICAL HOLDINGS, INC. |
|
|
|
|
By:
|
/s/
Sean E. Browne |
|
Name: |
Sean
E. Browne |
|
Title: |
President
and Chief Executive Officer |
Pursuant
to the requirements of the Securities Act of 1933, as amended, this Pre-Effective Amendment No. 1 to registration statement has been
signed by the following persons in the capacities and on the dates indicated.
Signature |
|
Capacity |
|
Date |
|
|
|
|
|
/s/
Sean E. Browne |
|
President
and Chief Executive Officer and Director |
|
July
11, 2023 |
Sean
E. Browne |
|
(Principal
Executive Officer) |
|
|
|
|
|
|
|
/s/
Scott Neils |
|
Chief
Financial Officer |
|
July
11, 2023 |
Scott
Neils |
|
(Principal
Financial Officer and Principal Accounting Officer) |
|
|
|
|
|
|
|
* |
|
Chair
of the Board of Directors |
|
July
11, 2023 |
Stavros
Vizirgianakis |
|
|
|
|
|
|
|
|
|
* |
|
Director
|
|
July
11, 2023 |
John
K. Bakewell |
|
|
|
|
|
|
|
|
|
* |
|
Director
|
|
July
11, 2023 |
Jonn
Beeson |
|
|
|
|
|
|
|
|
|
* |
|
Director
|
|
July
11, 2023 |
Robert
McNamara |
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
July
11, 2023 |
Lori
Mitchell-Keller |
|
|
|
|
*
By: |
/s/
Sean E. Browne |
|
|
Sean
E. Browne |
|
|
Attorney-in-fact |
|
Exhibit
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in this Registration Statement on Form S-3, as amended, of our report dated March 7, 2023 with
respect to the consolidated financial statements of Xtant Medical Holdings, Inc. included in its Annual Report on Form 10-K as of and
for the years ended December 31, 2022 and 2021. We also consent to the reference to us under the heading “Experts” in such
Registration Statement.
|
/s/
Plante & Moran, PLLC |
|
|
Denver,
Colorado |
|
July
11, 2023 |
|
Exhibit
23.3
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in this Registration Statement on Form S-3, as amended, of our report dated May 16, 2023 with
respect to the abbreviated financial statements of Surgalign SPV, Inc., which report appears in the Form 8-K/A of Xtant Medical Holdings,
Inc. filed May 16, 2023.
|
/s/
Plante & Moran, PLLC |
|
|
Denver,
Colorado |
|
July
11, 2023 |
|
Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From May 2024 to Jun 2024
Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From Jun 2023 to Jun 2024